Immuneel Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
111
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$10.5M
- Investors
-
19
Immuneel General Information
Description
Developer of cell and gene therapies designed to treat cancer. The company develops immunotherapies, including chimeric antigen receptor T-cell (CAR-T) therapies, that use genetically modified human immune cells to target cancer cells, enabling cancer patients to access cell-based treatments.
Contact Information
Website
www.immuneel.comCorporate Office
- 29/P2, 8th Floor Narayana Health City
- Hosur Road Bommasandra Industrial Area
- Bengaluru, Karnataka 560099
- India
Corporate Office
- 29/P2, 8th Floor Narayana Health City
- Hosur Road Bommasandra Industrial Area
- Bengaluru, Karnataka 560099
- India
Immuneel Timeline
Immuneel Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 08-Jun-2026 | $10.5M | Completed | Clinical Trials - General | ||
| 3. Later Stage VC (Series A) | 09-Jul-2024 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series A) | 11-Apr-2022 | $14.2M | $26.1M | Completed | Clinical Trials - General | |
| 1. Early Stage VC | 10-Aug-2020 | $11.8M | $11.8M | Completed | Clinical Trials - General |
Immuneel Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A Preference | ||||||||
| Ordinary | ||||||||
| Series A Preference | ||||||||
| Ordinary | 10 | $0.119762 | $1268.76 | $1268.76 | 1x | $1268.76 | 0.02% | |
| Ordinary | 17,978 | $0.119762 | $592.82 | $592.82 | 1x | $592.82 | 38.77% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Immuneel Comparisons
Industry
Financing
Details
Immuneel Competitors (1)
One of Immuneel’s competitors is Bugworks Research, a Private Equity-Backed company based in Wilmington, DE.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bugworks Research | Private Equity-Backed | Wilmington, DE |
Immuneel Patents
Immuneel Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026042055-A1 | Dual targeting cancer cell therapy for cd19 and cd20 | Pending | 23-Aug-2024 | ||
| AU-2025239922-A1 | A method for preparing chimeric antigen receptor (car) expressing cells | Pending | 18-Mar-2024 | ||
| WO-2025196582-A1 | A method for preparing chimeric antigen receptor (car) expressing cells | Pending | 18-Mar-2024 | ||
| WO-2024047558-A2 | Antigen-binding proteins and chimeric antigen receptors specific for domain 9 of human cd307e | Inactive | 31-Aug-2022 | ||
| WO-2024047558-A3 | Antigen-binding proteins and chimeric antigen receptors specific for domain 9 of human cd307e | Inactive | 31-Aug-2022 | C07K16/283 |
Immuneel Signals
Immuneel Investors (19)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Rainmatter Capital | Corporate Venture Capital | Minority | ||
| Singularity AMC | Growth/Expansion | Minority | ||
| Kotak Private Equity Group | PE/Buyout | Minority | ||
| taiba rare | Corporation | Minority |
Immuneel FAQs
-
When was Immuneel founded?
Immuneel was founded in 2018.
-
Where is Immuneel headquartered?
Immuneel is headquartered in Bengaluru, India.
-
What is the size of Immuneel?
Immuneel has 111 total employees.
-
What industry is Immuneel in?
Immuneel’s primary industry is Drug Discovery.
-
Is Immuneel a private or public company?
Immuneel is a Private company.
-
What is Immuneel’s current revenue?
The current revenue for Immuneel is .
-
How much funding has Immuneel raised over time?
Immuneel has raised $48.5M.
-
Who are Immuneel’s investors?
, Rainmatter Capital, Singularity AMC, Kotak Private Equity Group, and taiba rare are 5 of 19 investors who have invested in Immuneel.
-
Who are Immuneel’s competitors?
Bugworks Research is a competitor of Immuneel.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process